Bo Nickal, His Latest Message and What’s Next
On October 27, 2025, Bo Nickal posted a brief but pointed message on his X (formerly Twitter) account: “Main card UFC 322.
On October 27, 2025, Bo Nickal posted a brief but pointed message on his X (formerly Twitter) account: “Main card UFC 322.
Veteran fighter Jim Miller took aim at the controversial eye-poke that disrupted the heavyweight title main event at UFC 321.
In a high-profile return for two veteran combat athletes, Michael Chandler and Chad Mendes will headline the upcoming Real American Freestyle event, RAF03, scheduled for Saturday, November 29, 2025,...
After an eagerly awaited return to the cage, heavyweight champion Tom Aspinall found himself grappling with frustration, disappointment and physical pain following the abrupt end to his title defence...
Former UFC title contender and current analyst Chael Sonnen didn’t hold back after the controversial end to UFC 321 in Abu Dhabi, where heavyweight champion Tom Aspinall was ruled unable to...
UFC President Dana White confirmed that the promotion is moving quickly to rebook the heavyweight title fight between Tom Aspinall and Ciryl Gane following the controversial ending to their main...
The Etihad Arena in Abu Dhabi hosted UFC 321 on Saturday, October 25, 2025 — an event loaded with promise, high-stakes matchups, and a heavyweight title bout that ended in shocking fashion. Main...
The promotion’s next major event is titled ONE Fight Night 37: Kryklia vs. Agdeve, scheduled for Saturday, November 8, 2025, at the Lumpinee Boxing Stadium in Bangkok, Thailand.
Fight week for UFC 321 at the Etihad Arena has been anything but quiet. The card has undergone key shifts that are altering the storylines heading into one of the promotion's biggest international events of the year.
The atmosphere at UFC 321’s ceremonial weigh-ins in Abu Dhabi hit a fever pitch Friday night as heavyweight champion Tom Aspinall and challenger Ciryl Gane ca
Get the latest MMA news delivered to your inbox
We respect your privacy. Unsubscribe anytime.
Cookie Consent
We use cookies to enhance your browsing experience, serve personalized ads, and analyze our traffic. Essential cookies are necessary for site functionality. By clicking "Accept All", you consent to our use of cookies. You can customize your preferences or reject non-essential cookies.